<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01496846</url>
  </required_header>
  <id_info>
    <org_study_id>PG#N014189</org_study_id>
    <secondary_id>HUM00049692</secondary_id>
    <secondary_id>HUM00088384</secondary_id>
    <nct_id>NCT01496846</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars</brief_title>
  <acronym>ARTIC</acronym>
  <official_title>Articaine Versus Lidocaine Supplemental Infiltration Efficacy in Irreversible Pulpitis Mandibular Molars After Failed Inferior Alveolar Nerve Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dentsply International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to study the ability of a frequently used dental anesthetic
      (articaine) to achieve complete numbness of a diseased tooth with the most commonly used
      injection technique in the lower jaw (inferior alveolar nerve block: IANB). If this technique
      fails, a commonly used supplemental (SUP) technique with one of two possible dental
      anesthetics (lidocaine or articaine) will be given to evaluate the success/failure of
      complete numbness between the two anesthetics.

      Standardized administration of anesthesia is provided by controlled delivery using Midwest
      Comfort Control Syringe.

      The investigators hypothesize that supplemental infiltration anesthesia with articaine will
      give the same success rate as lidocaine in achieving complete pulpal anesthesia in mandibular
      molars with irreversible pulpits.

      This study consisted of two periods of patient enrollment, treatment and data collection:
      Part I: 101 subjects; Part II: 100 subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of the study is to achieve complete pulpal anesthesia in irreversible pulpitis
      mandibular molars, either by IANB administration of 4% articaine with 1:100,000 epinephrine
      (NDA 022466), or in case the IANB appeared to be clinically unsuccessful by supplemental
      infiltration of either articaine or lidocaine.

      The proposed randomized controlled trial (RCT) aims to answer the following questions:

        1. What is the success rate of an IANB with articaine using a conventional IANB technique
           and standardized speed of administration?

        2. Is there a difference in complete pulpal anesthetic efficacy using supplemental
           infiltration with either articaine or lidocaine after an unsuccessful articaine IANB?

        3. Is there a difference in first or second molars in achieving complete pulpal anesthesia
           using supplemental infiltration with either articaine or lidocaine?

      This study will combine the data from HUM00049692- Articaine Efficacy in Inflamed Molars to
      create a larger sample size, giving a total sample size of approximately 200 patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anesthetic Success Rate of Supplemental Infiltration Injection</measure>
    <time_frame>5 min after injection</time_frame>
    <description>Following an unsuccessful IANB, supplemental infiltration anesthesia with either articaine or lidocaine was given to achieve complete pulpal anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anesthetic Success Rate of an IANB With Articaine</measure>
    <time_frame>15 min after injection</time_frame>
    <description>Success rate of an IANB with articaine using a conventional IANB technique</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">201</enrollment>
  <condition>Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>IANB Articaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IANB Articaine: Inferior alveolar nerve block (IANB) anesthesia with articaine local anesthetic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SUP Articaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SUP Articaine: Supplemental buccal anesthesia (SUP) with articaine local anesthetic after unsuccessful IANB.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SUP Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SUP Lidocaine: Supplemental buccal anesthesia (SUP) with lidocaine local anesthetic after unsuccessful IANB.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IANB Articaine</intervention_name>
    <description>IANB anesthesia given with 1.7cc of 4% articaine, 1:100,000 epinephrine.</description>
    <arm_group_label>IANB Articaine</arm_group_label>
    <arm_group_label>SUP Articaine</arm_group_label>
    <arm_group_label>SUP Lidocaine</arm_group_label>
    <other_name>Articadent (Dentsply Pharmaceutical)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SUP Articaine</intervention_name>
    <description>After unsuccessful IANB with articaine, proceed to give 1.7cc of 4% articaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection (SUP).</description>
    <arm_group_label>SUP Articaine</arm_group_label>
    <other_name>Articadent (Dentsply Pharmaceutical)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SUP Lidocaine</intervention_name>
    <description>After unsuccessful IANB with articaine, proceed to give 1.7cc of 2% lidocaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection (SUP).</description>
    <arm_group_label>SUP Lidocaine</arm_group_label>
    <other_name>Generic lidocaine (Henry Schein Inc)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients

          -  irreversible pulpitis in mandibular molar

        Exclusion Criteria:

          -  below 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathilde C Peters, DMD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tatiana Botero, DDS, MS</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan, School of Dentistry Clinics</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brandt RG, Anderson PF, McDonald NJ, Sohn W, Peters MC. The pulpal anesthetic efficacy of articaine versus lidocaine in dentistry: a meta-analysis. J Am Dent Assoc. 2011 May;142(5):493-504.</citation>
    <PMID>21531931</PMID>
  </reference>
  <results_reference>
    <citation>Rogers BS, McDonald NJ, Gardner R, Botero T, Shlafer M, Peters MC. Anesthetic Efficacy of Articaine vs Lidocaine as Supplemental Infiltration after Unsuccessful IANB of Irreversible Pulpitis Mandibular Molars. AAE Annual Meeting. Honolulu, Hawaii, April 2013.</citation>
  </results_reference>
  <results_reference>
    <citation>Rogers BS, Botero TM, McDonald NJ, Gardner RJ, Peters MC. Efficacy of articaine versus lidocaine as a supplemental buccal infiltration in mandibular molars with irreversible pulpitis: a prospective, randomized, double-blind study. J Endod. 2014 Jun;40(6):753-8. doi: 10.1016/j.joen.2013.12.022. Epub 2014 Feb 8.</citation>
    <PMID>24862701</PMID>
  </results_reference>
  <results_reference>
    <citation>Shapiro MR, McDonald NJ, Gardner RJ, Peters MC, Botero TM. Efficacy of Articaine versus Lidocaine in Supplemental Infiltration for Mandibular First versus Second Molars with Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial. J Endod. 2018 Apr;44(4):523-528. doi: 10.1016/j.joen.2017.10.003. Epub 2018 Feb 1.</citation>
    <PMID>29397214</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2011</study_first_submitted>
  <study_first_submitted_qc>December 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2011</study_first_posted>
  <results_first_submitted>July 11, 2017</results_first_submitted>
  <results_first_submitted_qc>August 9, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">September 13, 2017</results_first_posted>
  <last_update_submitted>September 27, 2017</last_update_submitted>
  <last_update_submitted_qc>September 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Mathilde Peters, DMD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Articaine</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>Anesthesia, Local</keyword>
  <keyword>Endodontics</keyword>
  <keyword>Molar</keyword>
  <keyword>Dental Pulp Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Protocol enrollment: 201 subjects with 1 study tooth.</recruitment_details>
      <pre_assignment_details>All enrolled study participants (N=201) initially received an Articaine inferior alveolar nerve block (IANB).
If unsuccessful (N=149), this was followed by a supplemental dose (SUP) of either Articaine or Lidocaine.
Fifty-two subjects were excluded prior to assignment to groups due to inadequate lip numbness (N=2) or successful IANB (N=50).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>IANB Articaine Only - 1st Molar</title>
          <description>IANB anesthesia with articaine local anesthetic provided to 1st Molar.</description>
        </group>
        <group group_id="P2">
          <title>IANB Articaine Only - 2nd Molar</title>
          <description>IANB anesthesia with articaine local anesthetic provided to 2nd Molar.</description>
        </group>
        <group group_id="P3">
          <title>IANB Articaine and SUP Articaine - 1st Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with articaine local anesthetic provided to 1st Molar after unsuccessful IANB.</description>
        </group>
        <group group_id="P4">
          <title>IANB Articaine and SUP Articaine - 2nd Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with articaine local anesthetic provided to 2nd Molar after unsuccessful IANB.</description>
        </group>
        <group group_id="P5">
          <title>IANB Articaine and SUP Lidocaine - 1st Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with lidocaine local anesthetic provided to 1st Molar after unsuccessful IANB.</description>
        </group>
        <group group_id="P6">
          <title>IANB Articaine and SUP Lidocaine - 2nd Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with lidocaine local anesthetic provided to 2nd Molar after unsuccessful IANB.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>IANB Articaine (All Participants)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="36"/>
                <participants group_id="P4" count="40"/>
                <participants group_id="P5" count="35"/>
                <participants group_id="P6" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="36"/>
                <participants group_id="P4" count="40"/>
                <participants group_id="P5" count="35"/>
                <participants group_id="P6" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Inadequate lip numbness: &quot;missed&quot; block</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Supplemental Buccal Infiltration</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">No participants with successful IANB initially were brought forward to supplemental anesthetic</participants>
                <participants group_id="P2" count="0">No participants with successful IANB initially were brought forward to supplemental anesthetic</participants>
                <participants group_id="P3" count="36">Only after unsuccessful IANB.</participants>
                <participants group_id="P4" count="40">Only after unsuccessful IANB.</participants>
                <participants group_id="P5" count="35">Only after unsuccessful IANB.</participants>
                <participants group_id="P6" count="38">Only after unsuccessful IANB.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="36"/>
                <participants group_id="P4" count="40"/>
                <participants group_id="P5" count="35"/>
                <participants group_id="P6" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Overall number of participants include all enrolled subjects that received the initial IANB anesthesia.</population>
      <group_list>
        <group group_id="B1">
          <title>IANB Articaine Only - 1st Molar</title>
          <description>IANB anesthesia with articaine local anesthetic provided to 1st Molar</description>
        </group>
        <group group_id="B2">
          <title>IANB Articaine Only - 2nd Molar</title>
          <description>IANB anesthesia with articaine local anesthetic provided to 2nd Molar</description>
        </group>
        <group group_id="B3">
          <title>IANB Articaine and SUP Articaine - 1st Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with articaine local anesthetic provided to 1st Molar after unsuccessful IANB.</description>
        </group>
        <group group_id="B4">
          <title>IANB Articaine and SUP Articaine - 2nd Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with articaine local anesthetic provided to 2nd Molar after unsuccessful IANB.</description>
        </group>
        <group group_id="B5">
          <title>IANB Articaine and SUP Lidocaine - 1st Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with lidocaine local anesthetic provided to 1st Molar after unsuccessful IANB.</description>
        </group>
        <group group_id="B6">
          <title>IANB Articaine and SUP Lidocaine - 2nd Molar</title>
          <description>Supplemental buccal anesthesia (SUP) with lidocaine local anesthetic provided to 2nd Molar after unsuccessful IANB.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="36"/>
            <count group_id="B4" value="40"/>
            <count group_id="B5" value="35"/>
            <count group_id="B6" value="38"/>
            <count group_id="B7" value="201"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Two subjects (1 first molar, 1 second molar) were excluded from analysis due to inadequate lip numbness (&quot;missed block&quot;) after initial IANB Articaine.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="36"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="35"/>
                    <count group_id="B6" value="38"/>
                    <count group_id="B7" value="199"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35" spread="11"/>
                    <measurement group_id="B2" value="50" spread="18"/>
                    <measurement group_id="B3" value="40" spread="14"/>
                    <measurement group_id="B4" value="38" spread="15"/>
                    <measurement group_id="B5" value="35" spread="14"/>
                    <measurement group_id="B6" value="40" spread="14"/>
                    <measurement group_id="B7" value="39" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Two subjects (1 first molar, 1 second molar) were excluded from analysis due to inadequate lip numbness (&quot;missed block&quot;) after initial IANB Articaine.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="36"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="35"/>
                    <count group_id="B6" value="38"/>
                    <count group_id="B7" value="199"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="22"/>
                    <measurement group_id="B6" value="19"/>
                    <measurement group_id="B7" value="102"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="13"/>
                    <measurement group_id="B6" value="19"/>
                    <measurement group_id="B7" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <population>Two subjects (1 first molar, 1 second molar) were excluded from analysis due to inadequate lip numbness (&quot;missed block&quot;) after initial IANB Articaine.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="36"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="35"/>
                    <count group_id="B6" value="38"/>
                    <count group_id="B7" value="199"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="35"/>
                    <measurement group_id="B6" value="38"/>
                    <measurement group_id="B7" value="199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Anesthetic Success Rate of Supplemental Infiltration Injection</title>
        <description>Following an unsuccessful IANB, supplemental infiltration anesthesia with either articaine or lidocaine was given to achieve complete pulpal anesthesia</description>
        <time_frame>5 min after injection</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IANB Articaine and SUP Articaine - 1st Molar</title>
            <description>Supplemental buccal anesthesia with articaine local anesthetic provided to 1st Molar after unsuccessful IANB.</description>
          </group>
          <group group_id="O2">
            <title>IANB Articaine and SUP Articaine - 2nd Molar</title>
            <description>Supplemental buccal anesthesia with articaine local anesthetic provided to 2nd Molar after unsuccessful IANB.</description>
          </group>
          <group group_id="O3">
            <title>IANB Articaine and SUP Lidocaine - 1st Molar</title>
            <description>Supplemental buccal anesthesia with lidocaine local anesthetic provided to 1st Molar after unsuccessful IANB.</description>
          </group>
          <group group_id="O4">
            <title>IANB Articaine and SUP Lidocaine - 2nd Molar</title>
            <description>Supplemental buccal anesthesia with lidocaine local anesthetic provided to 2nd Molar after unsuccessful IANB.</description>
          </group>
        </group_list>
        <measure>
          <title>Anesthetic Success Rate of Supplemental Infiltration Injection</title>
          <description>Following an unsuccessful IANB, supplemental infiltration anesthesia with either articaine or lidocaine was given to achieve complete pulpal anesthesia</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="35"/>
                <count group_id="O4" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.901</p_value>
            <method>Chi-squared</method>
            <method_desc>We used the Chi-Square Test or Fisher's Exact test on the raw data depending on the number of data points in the table cells.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.004</p_value>
            <method>Chi-squared</method>
            <method_desc>We used the Chi-Square Test or Fisher's Exact test on the raw data depending on the number of data points in the table cells.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anesthetic Success Rate of an IANB With Articaine</title>
        <description>Success rate of an IANB with articaine using a conventional IANB technique</description>
        <time_frame>15 min after injection</time_frame>
        <population>All enrolled participants (N=201) received an IANB with Articaine. Two participants were excluded from data analysis due to inadequate lip numbness (IANB was considered &quot;missed block&quot;); thus N=199 were analyzed for success rate.</population>
        <group_list>
          <group group_id="O1">
            <title>IANB Articaine - 1st Molar</title>
            <description>Initial IANB (1.7cc 4% articaine with 1:100,000 epinephrine) provided to 1st Molar.</description>
          </group>
          <group group_id="O2">
            <title>IANB Articaine - 2nd Molar</title>
            <description>Initial IANB (1.7cc 4% articaine with 1:100,000 epinephrine) provided to 2nd Molar.</description>
          </group>
        </group_list>
        <measure>
          <title>Anesthetic Success Rate of an IANB With Articaine</title>
          <description>Success rate of an IANB with articaine using a conventional IANB technique</description>
          <population>All enrolled participants (N=201) received an IANB with Articaine. Two participants were excluded from data analysis due to inadequate lip numbness (IANB was considered &quot;missed block&quot;); thus N=199 were analyzed for success rate.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="98"/>
                <count group_id="O2" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.437</p_value>
            <method>Chi-squared</method>
            <method_desc>We used the Chi-Square Test or Fisher's Exact test on the raw data depending on the number of data points in the table cells.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Initial IANB Articaine</title>
          <description>Initial IANB with articaine local anesthetic.</description>
        </group>
        <group group_id="E2">
          <title>SUP Articaine</title>
          <description>Supplemental buccal anesthesia with articaine local anesthetic.</description>
        </group>
        <group group_id="E3">
          <title>SUP Lidocaine</title>
          <description>Supplemental buccal anesthesia with lidocaine local anesthetic.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="73"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="73"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="73"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Tatiana Botero, Director of Postgraduate Program in Endodontics</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-936-2526</phone>
      <email>tbotero@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

